Julian Emanuel of Evercore ISI says Trump's economic policies will be moderated and influenced by the bond markets. His does not see a significant downturn in the U.S. economy, explaining his S ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $60.00. The company’s shares closed yesterday at $45.78.

Evercore ISI analyst Amit Daryanani lowered the firm’s March-end quarter estimates for Seagate (STX) after the company filed an 8-K on December 3, noting they are experiencing some delays in ...

Evercore ISI expressed on Friday that Wall Street will likely see more of what it experienced in 2024, as the investment institution stated “Fill IT up again” in 2025 indicating its positive ...

NEW YORK, January 03, 2025--(BUSINESS WIRE)--Evercore (NYSE: EVR) will host its 11th annual Utility CEO Conference in Scottsdale, Arizona, Jan. 8-10, 2025. The power & utilities sector is rapidly ...

Evercore ISI anticipates a 22% growth in the S&P 500 Index to 7,200, up from its current level of 5,940, therefore signaling a great year for the stock market in 2025; among other tech firms, Nvidia ...

Evercore ISI analyst Glenn Schorr raised the firm’s price target on JPMorgan (JPM) to $264 from $238 and keeps an Outperform rating on the shares. Equity markets sold off by about 2% in December ...

Emphasizing the potential of firms positioned to profit from increased corporate use of artificial intelligence, Evercore ISI has released its top software stock recommendations for 2025. The company ...

Emphasizing the potential of firms positioned to profit from increased corporate use of artificial intelligence, Evercore ISI has released its top software stock recommendations for 2025.

Shares of Spero Therapeutics stock opened at $0.96 on Friday. Spero Therapeutics has a 12 month low of $0.95 and a 12 month high of $1.89. The business has a 50-day moving average of $1.20 and a ...